In Vitro and In Vivo Evaluation of ACE-Inhibitory Activity of Peptides from Seaweeds
Back to Projects
Biotechnology

In Vitro and In Vivo Evaluation of ACE-Inhibitory Activity of Peptides from Seaweeds

Evaluation of angiotensin-converting enzyme inhibitory activity of bioactive peptides derived from marine seaweeds through in vitro and in vivo experimental approaches.

This research focuses on the extraction, purification, and characterization of bioactive peptides from various species of marine seaweeds. The study evaluates the angiotensin-converting enzyme (ACE) inhibitory potential of these peptides through both in vitro enzymatic assays and in vivo animal model studies. Key Highlights: - Identification of novel ACE-inhibitory peptides from marine algae - In vitro IC50 determination for purified peptide fractions - In vivo validation using spontaneously hypertensive rat models - Structure-activity relationship analysis - Potential application in functional food development This project contributes to the growing field of marine pharmacology and nutraceutical research, offering natural alternatives for hypertension management.

Research Details

Research Area
Biotechnology
Date
13 June 2026
Status
Published

Need Research Guidance?

Our expert mentors can help you with similar research projects and publications.

Get in Touch

Explore More Research

View All Projects